Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/24823
Title: Ondansetron and granisetron in the prophylaxis of nausea and emesis induced by cisplatin in dogs
Authors: Uludağ Üniversitesi/Veteriner Fakültesi/Cerrahi Anabilim Dalı.
Topal, Ayşe
Kaya, Metin
Gül, Nihal
56357211200
55417963000
55899103700
Keywords: Veterinary sciences
5-HT3 receptor antagonist
Vomiting
Emetic response
Canine
Delayed emesis
In-vivo
Chemotherapy
Dexamethasone
Zacopride
Ferret
Pigeon
Model
Issue Date: Mar-2005
Publisher: Veterinarni a Farmaceuticka Univerzita Brno
Citation: Topal, A. vd. (2005). "Ondansetron and granisetron in the prophylaxis of nausea and emesis induced by cisplatin in dogs". Acta Veterinaria Brno, 74(1), 111-116.
Abstract: In the present study, the effects of 5-HT3 receptor antagonist granisetron and ondansetron on the acute phase of cisplatin-induced nausea and emesis were analyzed in dogs. Fifteen healty dogs were used in this study. Cisplatin was administrated to all dogs to induce nausea and vomiting. All dogs that received cisplatin (3 mg/kg IV) were observed continuously for 8 It. Five dogs administered only cisplatin acted as controls. Cisplatin induced emetic response and nausea was detected in the controls. Ondansetron (1 mg/kg IV) and granisetron (60 mu g/kg IV) were administered to the other animals 30 min. before cisplatin administration. Although acute vomiting was significantly inhibited by ondansetron and granisetron, granisetron was found more effective on the nausea. It was concluded that both ondansetron and granisetron are effective in the control of cisplatin-induced vomiting in dogs, but granisetron is more effective than ondansetron in the inhibition of cisplatin-induced nausea in dogs.
URI: https://doi.org/10.2754/avb200574010111
https://actavet.vfu.cz/74/1/0111/
http://hdl.handle.net/11452/24823
ISSN: 0001-7213
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Topal_vd_2005.pdf124.9 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons